Evidence map›Paper›PMID 21775457›Full record

ArticleJournal of virology2011

The TRIM5 gene modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys.

Wendy W Yeh, Srinivas S Rao, So-Yon Lim, Jinrong Zhang, Peter T Hraber, Laura M Brassard, Corinne Luedemann, John Paul Todd, Alan Dodson, Ling Shen and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Strong TScience translational medicine · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Impact of TRIM5α in vivo.AIDS (London, England) · 2015
    Review
  15. Article
  16. Article
  17. Nonhuman primate models for HIV/AIDS vaccine development.Current protocols in immunology · 2013
    Review
  18. Using nonhuman primates to model HIV transmission.Current opinion in HIV and AIDS · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Wendy W YehBeth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Srinivas S Rao
So-Yon Lim
Jinrong Zhang
Peter T Hraber
Laura M Brassard
Corinne Luedemann
John Paul Todd
Alan Dodson
Ling Shen
Adam P Buzby
James B Whitney
Bette T Korber
Gary J Nabel
John R Mascola
Norman L Letvin
Harvard University Press · USBeth Israel Deaconess Medical Center · USLos Alamos National Laboratory · USNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USBioqual · US

Funding

Viral Sequencing CoreU19AI067854 · NIAID · DUKE UNIVERSITY · PI LETVIN, NORMAN L · 2006 to 2011
$290.5M
The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Non Human Primate Models of SIV and HIV Immune ProtectionZIAAI005009 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MASCOLA, JOHN · 2009 to 2018
$5.8M
Non-human Primate Immunogenicity Studies of HIV-1 immunogensZIAAI005011 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MASCOLA, JOHN · 2009 to 2013
$1.5M
Viral Constraints on SIV Escape from Cytotoxic T LymphocytesK08AI069995 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI YEH, WENDY WEN-LI · 2006 to 2010
$585k
A SIV/Rhesus Monkey Penile Mucosal Transmission ModelR21AI093199 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SANTRA, SAMPA · 2011 to 2011
$222k
NCRR NIH HHS UL1 RR 025758NCRR NIH HHS UL1 RR025758NIAID NIH HHS K08 AI069995NIAID NIH HHS P30 AI060354NIAID NIH HHS P30AI060354NIAID NIH HHS R21 AI093199NIAID NIH HHS U19 AI067854
6 · The paper itself

Abstract

There is considerable variability in host susceptibility to human immunodeficiency virus type 1 (HIV-1) infection, but the host genetic determinants of that variability are not well understood. In addition to serving as a block for cross-species retroviral infection, TRIM5 was recently shown to play a central role in limiting primate immunodeficiency virus replication. We hypothesized that TRIM5 may also contribute to susceptibility to mucosal acquisition of simian immunodeficiency virus (SIV) in rhesus monkeys. We explored this hypothesis by establishing 3 cohorts of Indian-origin rhesus monkeys with different TRIM5 genotypes: homozygous restrictive, heterozygous permissive, and homozygous permissive. We then evaluated the effect of TRIM5 genotype on the penile transmission of SIVsmE660. We observed a significant effect of TRIM5 genotype on mucosal SIVsmE660 acquisition in that no SIV transmission occurred in monkeys with only restrictive TRIM5 alleles. In contrast, systemic SIV infections were initiated after preputial pocket exposures in monkeys that had at least one permissive TRIM5 allele. These data demonstrate that host genetic factors can play a critical role in restricting mucosal transmission of a primate immunodeficiency virus. In addition, we used our understanding of TRIM5 to establish a novel nonhuman primate penile transmission model for AIDS mucosal pathogenesis and vaccine research.

Indexed as

Genetic Predisposition to DiseaseAnimalsCarrier ProteinsGenotypeMacaca mulattaMaleMucous MembranePenisSimian Immunodeficiency VirusCarrier Proteins

Identifiers

PMID21775457
PMCPMC3196432
OpenAlexW2124651887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.